Credit where it is due, PR and Co. have really structured things in a way to help turn things around in the most dramatic way possible. A brilliant way to top things off will be a partnership deal. Just imagine if PR announces a China deal in the next two weeks? Unlikely, but wouldn't it just top things off nicely?
MRI results in conjunction with all other results confirm DMOAD. I must admit that I only expected an improvement to BML at 6 months and no improvement in cartilage at 6 months since it just seemed too soon. iPPS basically now ticks all the boxes; pain and function, biomarkers, durability, mri etc. We can also expect a favourable outcome at the upcoming FDA meeting in Q1.
GLTAH
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-83
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.8¢ |
Change
0.003(0.85%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.5¢ | $34.53K | 115.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 40539 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 56 | 1 |
View Market Depth
| Last trade - 15.59pm 22/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |